DDInter1631 DDInter1186
Safinamide is for the treatment of parkinson's disease. It was approved in Europe in February 2015, and in the United States on March 21, 2017.
Methylene blue is an oxidation-reduction agent. The intravenous form of methylene blue is approved by the FDA for the treatment of pediatric and adult patients with acquired methemoglobinemia. Historically, it has been widely used in Africa to treat malaria, but now it disappeared when chloroquine (CQ) and other drugs entered the market. Its use as an urinary tract antiseptic has also been investigated. Methylthioninium chloride (INN, or methylene blue, proposed trade name Rember) is an investigational drug being developed by the University of Aberdeen and TauRx Therapeutics that has been shown in early clinical trials to be an inhibitor of Tau protein aggregation. The drug is of potential interest for the treatment of patients with Alzheimer's disease.
Methylene blue {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Ritodrine
Methylene blue {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Levosalbutamol
Methylene blue {u} may lead to a major life threatening interaction when taken with {v} Phentermine
Methylene blue {u} may lead to a major life threatening interaction when taken with {v} Valbenazine
Methylene blue {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} and {u} may lead to a major life threatening interaction when taken with {v} Tetryzoline
Methylene blue may cause a moderate interaction that could exacerbate diseases when taken with Ritodrine
Methylene blue may cause a moderate interaction that could exacerbate diseases when taken with Levosalbutamol
Methylene blue may lead to a major life threatening interaction when taken with Phentermine
Methylene blue may lead to a major life threatening interaction when taken with Valbenazine
Methylene blue may cause a moderate interaction that could exacerbate diseases when taken with Tetryzoline and Methylene blue may lead to a major life threatening interaction when taken with Tetryzoline